vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Third Coast Bancshares, Inc. (TCBX). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $57.7M, roughly 1.1× Third Coast Bancshares, Inc.). Third Coast Bancshares, Inc. runs the higher net margin — 28.4% vs -70.9%, a 99.3% gap on every dollar of revenue. Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 17.5%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Third Coast Bancshares, Inc. is a regional financial holding company headquartered in the U.S. Gulf Coast region. It provides a full suite of commercial and retail banking services including deposit products, business and consumer loans, mortgage services, and wealth management solutions, serving local small and medium-sized enterprises, individual consumers, and community clients across Texas and surrounding areas.
CTKB vs TCBX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $57.7M |
| Net Profit | $-44.1M | $16.4M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | — |
| Net Margin | -70.9% | 28.4% |
| Revenue YoY | 8.1% | — |
| Net Profit YoY | -557.1% | 20.5% |
| EPS (diluted) | — | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $57.7M | ||
| Q4 25 | $62.1M | $56.5M | ||
| Q3 25 | $52.3M | $54.5M | ||
| Q2 25 | $45.6M | $52.0M | ||
| Q1 25 | $41.5M | $45.9M | ||
| Q4 24 | $57.5M | $46.3M | ||
| Q3 24 | $51.5M | $42.9M | ||
| Q2 24 | $46.6M | $41.7M |
| Q1 26 | — | $16.4M | ||
| Q4 25 | $-44.1M | $17.9M | ||
| Q3 25 | $-5.5M | $18.1M | ||
| Q2 25 | $-5.6M | $16.7M | ||
| Q1 25 | $-11.4M | $13.6M | ||
| Q4 24 | $9.6M | $13.7M | ||
| Q3 24 | $941.0K | $12.8M | ||
| Q2 24 | $-10.4M | $10.8M |
| Q1 26 | — | — | ||
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | -9.0% | 38.1% | ||
| Q3 25 | -17.6% | 41.9% | ||
| Q2 25 | -23.3% | 40.5% | ||
| Q1 25 | -36.1% | 37.8% | ||
| Q4 24 | 5.2% | 38.7% | ||
| Q3 24 | -8.2% | 37.9% | ||
| Q2 24 | -18.3% | 34.1% |
| Q1 26 | — | 28.4% | ||
| Q4 25 | -70.9% | 31.7% | ||
| Q3 25 | -10.5% | 33.1% | ||
| Q2 25 | -12.2% | 32.2% | ||
| Q1 25 | -27.5% | 29.6% | ||
| Q4 24 | 16.8% | 29.7% | ||
| Q3 24 | 1.8% | 29.8% | ||
| Q2 24 | -22.4% | 25.9% |
| Q1 26 | — | $0.88 | ||
| Q4 25 | — | $1.02 | ||
| Q3 25 | — | $1.03 | ||
| Q2 25 | — | $0.96 | ||
| Q1 25 | — | $0.78 | ||
| Q4 24 | — | $0.80 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | — | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $650.5M |
| Total Assets | $461.5M | $6.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $90.9M | $175.2M | ||
| Q3 25 | $93.3M | $116.4M | ||
| Q2 25 | $75.5M | $113.1M | ||
| Q1 25 | $95.3M | $219.0M | ||
| Q4 24 | $98.7M | $371.2M | ||
| Q3 24 | $162.3M | $258.2M | ||
| Q2 24 | $177.9M | $241.8M |
| Q1 26 | — | $650.5M | ||
| Q4 25 | $341.7M | $531.0M | ||
| Q3 25 | $378.6M | $513.8M | ||
| Q2 25 | $377.6M | $496.1M | ||
| Q1 25 | $379.6M | $479.8M | ||
| Q4 24 | $395.7M | $460.7M | ||
| Q3 24 | $385.5M | $450.5M | ||
| Q2 24 | $389.1M | $435.0M |
| Q1 26 | — | $6.6B | ||
| Q4 25 | $461.5M | $5.3B | ||
| Q3 25 | $494.9M | $5.1B | ||
| Q2 25 | $493.3M | $4.9B | ||
| Q1 25 | $482.6M | $4.9B | ||
| Q4 24 | $499.5M | $4.9B | ||
| Q3 24 | $491.2M | $4.6B | ||
| Q2 24 | $483.7M | $4.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | — |
| Free Cash FlowOCF − Capex | $-1.8M | — |
| FCF MarginFCF / Revenue | -2.9% | — |
| Capex IntensityCapex / Revenue | 1.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-771.0K | $50.8M | ||
| Q3 25 | $-3.9M | $20.7M | ||
| Q2 25 | $108.0K | $13.9M | ||
| Q1 25 | $-125.0K | $10.5M | ||
| Q4 24 | $2.0M | $35.1M | ||
| Q3 24 | $13.2M | $22.0M | ||
| Q2 24 | $6.2M | $7.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | $33.4M | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -2.9% | — | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | 72.1% | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.6% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | 3.8% | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.84× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | 0.21× | 2.56× | ||
| Q3 24 | 14.05× | 1.72× | ||
| Q2 24 | — | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
TCBX
| Net Interest Income | $53.6M | 93% |
| Noninterest Income | $4.0M | 7% |
